Benjamin Bulkley, former senior vice president of global commercial operations for Invitrogen, has been named COO of Allscripts Healthcare Solutions, an electronic health records software manufacturer.
Transgenomic has named Frank Witney to its board of directors.
Witney is president, CEO and director of Panomics, and is a director of Applied Precision. He also has been president of PerkinElmer’s drug-discovery business and was COO of Packard Biosciences.
Enigma Diagnostics this week named Lynn Busteed to be its new CEO and director. Busteed was previously vice president for corporate development at Focus Diagnostics and was senior director of business development and strategic planning at Celera Genomics.